Cargando…
Survivin in Insulin-Like Growth Factor-Induced Resistance to Lapatinib in Head and Neck Squamous Carcinoma Cells
Epidermal growth factor receptor (EGFR) inhibitors have limited efficacy in head and neck squamous cell carcinoma (HNSCC) due to various resistance mechanisms, such as activation of the insulin-like growth factor-1 receptor (IGF1R), which initiates pro-survival signaling. Survivin, a member of the i...
Autores principales: | Lehman, Christine E., Mendez, Rolando E., Dougherty, Michael I., Allak, Amir, Adejumo, Oluwayemisi L., Taniguchi, Linnea E., Khalil, Ashraf, Gioeli, Daniel G., Jameson, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351440/ https://www.ncbi.nlm.nih.gov/pubmed/30729097 http://dx.doi.org/10.3389/fonc.2019.00013 |
Ejemplares similares
-
Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib
por: Gandhi, Mitul D, et al.
Publicado: (2014) -
Cytotoxic effect of lapatinib is restricted to human papillomavirus-positive head and neck squamous cell carcinoma cell lines
por: Fumagalli, Ingrid, et al.
Publicado: (2015) -
Metastatic squamous cell carcinoma of the skin with clinical response to lapatinib
por: Strickley, John D., et al.
Publicado: (2018) -
Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment
por: Eljack, Sahar, et al.
Publicado: (2022) -
Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma
por: Zhang, L, et al.
Publicado: (2015)